1-5 of 5
Xuan Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma

Jiayi Yu, Junya Yan, Qian Guo, Zhihong Chi, Bixia Tang, Bin Zheng, Jinyu Yu, Ting Yin, Zhiyuan Cheng, Xiaowen Wu, Huan Yu, Jie Dai, Xinan Sheng, Lu Si, Chuanliang Cui, Xue Bai, Lili Mao, Bin Lian, Xuan Wang, Xieqia Yan, Siming Li, Li Zhou, Keith T. Flaherty, Jun Guo, Yan Kong
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (21): 6511–6523.
https://doi.org/10.1158/1078-0432.CCR-19-0475
Published: 01 November 2019
View article titled, Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Open the PDF for Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma in another window
Includes: Supplementary data
Journal Articles

Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies

Yu Zhao, Zhongfeng Liu, Xuan Wang, Huantong Wu, Jianping Zhang, Junfang Yang, Fayou Zhang, Lining Liu, Jiafu Long, Peihua Lu, Zhiguo Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5595–5607.
https://doi.org/10.1158/1078-0432.CCR-19-0916
Published: 13 September 2019
View article titled, Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies
Open the PDF for Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma

Yuanfeng Li, Yun Zhai, Qingfeng Song, Haitao Zhang, Pengbo Cao, Jie Ping, Xinyi Liu, Bingqian Guo, Guanjun Liu, Jin Song, Ying Zhang, Aiqing Yang, Hongbo Yan, Liang Yang, Ying Cui, Yilong Ma, Jinliang Xing, Xizhong Shen, Taotao Liu, Hongxin Zhang, Jiaze An, Jin-Xin Bei, Weihua Jia, Longli Kang, Lijun Liu, Dongya Yuan, Zhibin Hu, Hongbing Shen, Lei Lu, Xuan Wang, Hua Li, Fuchu He, Hongxing Zhang, Gangqiao Zhou
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 906–915.
https://doi.org/10.1158/1078-0432.CCR-17-2537
Published: 14 February 2018
View article titled, Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma
Open the PDF for Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy

Yan Kong, Xinan Sheng, Xiaowen Wu, Junya Yan, Meng Ma, Jiayi Yu, Lu Si, Zhihong Chi, Chuanliang Cui, Jie Dai, Yiqian Li, Huan Yu, Tianxiao Xu, Huan Tang, Bixia Tang, Lili Mao, Bin Lian, Xuan Wang, Xieqiao Yan, Siming Li, Jun Guo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (22): 6946–6957.
https://doi.org/10.1158/1078-0432.CCR-17-0070
Published: 14 November 2017
View article titled, Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
Open the PDF for Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases

Xue Bai, Yan Kong, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Xuan Wang, Lili Mao, Bixia Tang, Siming Li, Bin Lian, Xieqiao Yan, Li Zhou, Jie Dai, Jun Guo, Lu Si
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6120–6127.
https://doi.org/10.1158/1078-0432.CCR-17-0980
Published: 12 October 2017
View article titled, <em>MAPK</em> Pathway and <em>TERT</em> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Open the PDF for <em>MAPK</em> Pathway and <em>TERT</em> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases in another window
Includes: Supplementary data